◀ Back to VIP

HCL2 — VIP

Text-mined interactions from Literome

García et al., Arch Int Physiol Biochim Biophys 1993 : Dose-response effect of intraduodenal HCl on exocrine pancreatic secretion, portal secretin, and VIP plasma levels in anesthetized rats
Bragado et al., Gen Pharmacol 1993 : 4. On the contrary, the ganglion blocker significantly ( P < 0.01 ) reduced plasma VIP levels in response to intraduodenal HCl ( maximum response 320 +/- 74 % in untreated vs 184 +/- 44 % in hexamethonium treated animals )
Chaiseha et al., Neuroendocrinology 1997 : The D1 DA agonist ( + ) -SKF-38393 HCl increased VIP release from 52.7 +/- 4.6 to 192.6 +/- 16.9 pg/5 min, and this stimulated release was partially inhibited by the D2 DA receptor agonist R ( - ) -NPA HCl ( from 192.6 +/- 16.9 to 139.7 +/- 13.8 pg/5 min )